John E. Edwards
Fondatore presso NovaDigm Therapeutics, Inc.
Posizioni attive di John E. Edwards
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of California, Los Angeles | Corporate Officer/Principal | - | - |
NovaDigm Therapeutics, Inc.
 NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND. | Fondatore | 01/01/2005 | - |
Storia della carriera di John E. Edwards
Precedenti posizioni note di John E. Edwards
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
NIH Research, Inc.
 NIH Research, Inc. Miscellaneous Commercial ServicesCommercial Services NIH Research, Inc. provided healthcare consulting services. The company was headquartered in Coral Springs, FL. | Corporate Officer/Principal | - | - |
Formazione di John E. Edwards
| Pomona College | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 4 |
| Commercial Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
NIH Research, Inc.
NIH Research, Inc. Miscellaneous Commercial ServicesCommercial Services NIH Research, Inc. provided healthcare consulting services. The company was headquartered in Coral Springs, FL. | Commercial Services |
NovaDigm Therapeutics, Inc.
NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND. | Health Technology |
- Borsa valori
- Insiders
- John E. Edwards
- Esperienza
